| 000 | 00913cam a2200277 4500 | ||
|---|---|---|---|
| 001 | vtls000082588 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250608184424.0 | ||
| 008 | 050818s1972 enka b 001 0 eng | ||
| 010 | _a72-075311 | ||
| 020 | _a0080168515 | ||
| 039 |
_a200508191440 _b900 _c200508181144 _d918 _y200508180915 _z918 |
||
| 040 |
_aDLC _cDLC _dUG-KaMUL |
||
| 082 | 0 | _a591.19 LEF | |
| 100 | 1 |
_aLefáebvre, P. J. _q(Pierre J.), _d1934- |
|
| 245 | 1 |
_aGlucagon : _bmolecular physiology, clinical and therapeutic implica tions / _cEdited by Pierre J. Lefebvre and Roger H. Unger. |
|
| 250 | _a1st ed. | ||
| 260 |
_aOxford : _aNew York : _bPergamon Press , _c1972. |
||
| 300 |
_axiii, 370 p. : _bill. ; _c26 cm. |
||
| 504 | _aIncludes bibliographical references. | ||
| 650 | _aGlucagon. | ||
| 700 | 1 |
_aUnger, Roger H., _ejoint author. |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c102136 _d102136 |
||